Article
- The EMBO Journal (2001) 20, 743 - 754
- doi:10.1093/emboj/20.4.743
Phospholipase C
: a novel Ras effector
Grant G. Kelley1, Sarah E. Reks1, Joanne M. Ondrako1 and Alan V. Smrcka2
- Departments of Medicine and Pharmacology, SUNY Upstate Medical University, 750 East Adams Street, Syracuse, NY 13210, USA
- Department of Pharmacology and Physiology, University of Rochester School of Medicine and Dentistry, 601 Elmwood Avenue, Box 711, Rochester, NY 14642, USA
Correspondence to:
Grant G. Kelley, E-mail: kelleyg@mail.upstate.edu
Received 7 November 2000; Accepted 22 December 2000; Revised 20 December 2000
Abstract
Three classes of mammalian phosphoinositide-specific phospholipase C (PLC) have been characterized, PLC
, PLC
and PLC
, that are differentially regulated by heterotrimeric G-proteins, tyrosine kinases and calcium. Here we describe a fourth class, PLC
, that in addition to conserved PLC domains, contains a GTP exchange factor (GRF CDC25) domain and two C-terminal Ras-binding (RA) domains, RA1 and RA2. The RA2 domain binds H-Ras in a GTP-dependent manner, comparable with the Ras-binding domain of Raf-1; however, the RA1 domain binds H-Ras with a low affinity in a GTP-independent manner. While G
q, G
or, surprisingly, H-Ras do not activate recombinant purified protein in vitro, constitutively active Q61L H-Ras stimulates PLC
co-expressed in COS-7 cells in parallel with Ras binding. Deletion of either the RA1 or RA2 domain inhibits this activation. Site-directed mutagenesis of the RA2 domain or Ras demonstrates a conserved Ras–effector interaction and a unique profile of activation by Ras effector domain mutants. These studies identify a novel fourth class of mammalian PLC that is directly regulated by Ras and links two critical signaling pathways.
Keywords:
- GTP-binding protein Ras,
- GTP exchange factor,
- phospholipase C,
- Raf-1,
- Ras-binding domain



